BioLegend · 3 weeks ago
Quality Control Associate II, Flow Cytometry
BioLegend is committed to providing researchers with high-quality reagents for life science research. The QC Associate II will test products and perform various laboratory functions, contributing to the quality control of reagents used in scientific research.
BioinformaticsBiotechnologyCollaborationHealth CareManufacturingMedicalNeurosciencePharmaceutical
Responsibilities
Perform testing of products in a timely manner
Perform aseptic cell culture
Isolate primary cells and tissues
Perform data analysis and document results
Maintain a safe and clean laboratory
Assist with troubleshooting projects, generate data summaries
Support efficiency and process improvement projects
Train others on specific laboratory protocols
Other projects or responsibilities as may be required
Qualification
Required
Bachelor's degree in a scientific discipline
Minimum 1 year experience with some of the following applications: Flow Cytometry, Western Blotting, Immunoprecipitation, Bioassays, ELISA and IHC/ICC
>3 years working experience in a laboratory environment
Preferred
Experience in sterile cell culture technique
Excellent organization, communication, and problem-solving skills
Proven ability to multi-task
Excellent documentation skills
Benefits
Medical, Dental, and Vision Insurance Options
Life and Disability Insurance
Paid Time-Off
Parental Benefits
Compassionate Care Leave
401k with Company Match
Employee Stock Purchase Plan
Company
BioLegend
BioLegend is a biotechnology firm that offers immunological reagents for biomedical research.
H1B Sponsorship
BioLegend has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (6)
2022 (2)
Funding
Current Stage
Late StageTotal Funding
unknown2021-07-26Acquired
Recent News
2025-05-06
Company data provided by crunchbase